Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 828

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 828
---
 ​ | ​              | ​ | 26,879 | ​ | ​ | ​ | ​                | ​ | 2 | ​ | ​ | ​ | ​      | ​ |     -6 | ​ | ​ | ​ | ​                   | ​ | 26,875 | ​ | ​ |
| Municipal bonds                                | ​ | ​ | ​              | ​ | 22,473 | ​ | ​ | ​ | ​                | ​ | — | ​ | ​ | ​ | ​      | ​ |   -402 | ​ | ​ | ​ | ​                   | ​ | 22,071 | ​ | ​ |
| Total available-for-sale marketable securities | ​ | ​ | ​              | $ | 94,680 | ​ | ​ | ​ | ​                | $ | 2 | ​ | ​ | ​ | ​      | $ | -1,674 | ​ | ​ | ​ | ​                   | $ | 93,008 | ​ | ​ |

The following tables summarize the fair value and gross unrealized losses of the Company’s available-for-sale marketable securities by investment category and disaggregated by the length of time that individual debt securities have been in a continuous unrealized loss position as of December 31, 2023 and 2022:

F-55

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(amounts in thousands, except share and per share data) As of December 31, 2023

| ​                                  
 ​                                  | ​ 
 ​ | ​ 
 ​ | Less than 12 Months 
 FairValue           |   |   |   | ​ | ​ | GrossUnrealizedLosses |   |   |   | ​ 
 ​ | ​ 
 ​ | 12 Months or Greater 
 FairValue            |   |       |   | ​ | ​ | GrossUnrealizedLosses |   |      |   | ​ 
 ​ | ​ 
 ​ | Total     
 FairValue |   |       |   | ​ | ​ | GrossUnrealizedLosses |   |      |   | ​ 
 ​ |
|:-----------------------------------|:--|:--|:--------------------|:--|:--|:--|:--|:--|:----------------------|:--|:--|:--|:--|:--|:---------------------|:--|------:|:--|:--|:--|:----------------------